CSI Market
Sign In | Register

Teladoc Health Inc (TDOC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TDOC Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Teladoc Health Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-102.75
Depreciation & amortization4.93
Amortization of Other Assets178.27
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss12.88
Provision For Loan Losses Expensed0.81
Increase (Decrease) in Inventories-8.63
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation23.91
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Accretion Of Interest-
Deferred Income Tax Noncash Expense Benefit-
Depreciation Of Rental Equipment-
Operating Lease Right Of Use Asset Amortization Expense1.90
Amortization Of Right Of Use Assets And Depreciation Of Rental Equipment-
Increase Decrease In Contract With Customer Liability5.06
Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation39.11
Income taxes0.00
Realized Investment Gains (Losses), Total0.00
Accounts Receivable-2.60
Increase (Decrease) in Accounts Payable-9.66
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets17.07
Other Working Capital-2.25
Other Noncash Income (Expense)-2.81
Other net0.00
Payments for (Proceeds from) Other Operating Activities-34.99
Discontinued operations0.00
Net Cash flow from Operating Activities74.18
Investing Activities
Capital Expenditures-77.42
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Available-for-sale Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-0.70
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-78.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.27
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.85
Other net0.00
Proceeds From Stock Options And Warrants Exercised-
Cash Related To Tax Withholding For Share Based Compensation Net-
Contingent Consideration Fair Value Adjustment Cash Flow Impact-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents781.08
Payments For Repurchase Of Convertible Debt-
Proceeds From Advances From Financing Companies-
Payments From Customers Against Advances From Financing Companies-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1.57
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.24
Total Cash Flow-5.51
4 historic quarters locked

Sign in to unlock the full Teladoc Health Inc cash flow history.

Sign In Create Free Account

About Teladoc Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477449-26-000038

Figures are derived from filed reports and may be restated. Historical data is subject to revision.